Special report: C-reactive protein for risk stratification in coronary heart disease screening

TEC Bull (Online). 2002 Nov 11;19(3):31-7.
No abstract available

MeSH terms

  • Biomarkers / analysis
  • Blue Cross Blue Shield Insurance Plans
  • C-Reactive Protein / metabolism*
  • Cardiovascular Diseases / diagnosis*
  • Drug Approval
  • Evidence-Based Medicine
  • Humans
  • Insurance Coverage
  • Outcome Assessment, Health Care
  • Predictive Value of Tests
  • Risk Assessment
  • Technology Assessment, Biomedical*
  • United States
  • United States Food and Drug Administration

Substances

  • Biomarkers
  • C-Reactive Protein